

Vapi Pharmaceuticals Llp loan details
Charges taken from banks & financial institutesData last updated:
Vapi Pharmaceuticals Llp has 7 charges registered with the Registrar of Companies: 5 open charges worth Rs 45.71 Cr and 2 satisfied charges worth Rs 17.13 Cr. The lender named on its open charges is Icici Bank Limited. The most recent charge was created on 31 May 2025 in favour of Icici Bank Limited for Rs 17.50 Cr and is open.
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 45.71 Cr
₹45.71 crore
₹17.13 crore
2
Icici Bank Limited
Creation
31 May 2025
₹17.50 cr
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 100364943 View Details | Icici Bank Limited | ₹ 2.28 | 25 Jun 2020 | 08 Jul 2022 | 03 Jan 2024 | Satisfied |
| 100070940 View Details | State Bank Of India | ₹ 14.85 | 10 Oct 2016 | 05 Jan 2018 | 18 Mar 2019 | Satisfied |
| 101103540 View Details | Icici Bank Limited | ₹ 17.50 | 31 May 2025 | - | - | Open |
| 100850237 View Details | Icici Bank Limited | ₹ 11.34 | 21 Dec 2023 | 15 Oct 2024 | - | Open |
| 100850239 View Details | Icici Bank Limited | ₹ 0.87 | 21 Dec 2023 | - | - | Open |
| 100403666 View Details | Icici Bank Limited | ₹ 3.00 | 28 Dec 2020 | 18 Jan 2021 | - | Open |
| 100243065 View Details | Icici Bank Limited | ₹ 13.00 | 08 Mar 2019 | 15 Jul 2021 | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.